In contrast, during tumour progression, the suppressive effect of TGFβ is lost, and in certain cancers, corruption of the signalling pathway can result in TGFβ exerting a pro-oncogenic effect7,10,11. The gene discussed is TGFB1; the disease is neoplasm.